Precision Therapeutics Inc (NASDAQ:POAI) saw a significant growth in short interest in the month of November. As of November 29th, there was short interest totalling 69,900 shares, a growth of 12.7% from the November 14th total of 62,000 shares. Approximately 2.2% of the shares of the stock are short sold. Based on an average daily trading volume, of 24,700 shares, the short-interest ratio is currently 2.8 days.
NASDAQ:POAI traded up $0.16 during trading hours on Friday, hitting $2.88. 15,048 shares of the company’s stock traded hands, compared to its average volume of 39,812. Precision Therapeutics has a 52 week low of $2.35 and a 52 week high of $11.50. The company has a fifty day moving average of $3.29. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.08 and a current ratio of 0.10.
Separately, ValuEngine raised Precision Therapeutics from a “hold” rating to a “buy” rating in a research note on Tuesday, December 3rd.
About Precision Therapeutics
Predictive Oncology Inc provides various healthcare products and services primarily in the United States. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. It offers the STREAMWAY Fluid Waste Management system that suctions surgical waste fluid from the patient using standard surgical tubing; and disposables.
Read More: What is a Lock-Up Period?
Receive News & Ratings for Precision Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precision Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.